A core theme of your review is that increased monitoring leads to the discovery of preexisting, indolent nodules
Injectable Semaglutide : Comes in various strengths, including 0.25 mg, 0.5 mg, 1 mg, and 2 mg pens, allowing for a gradual increase in dosage as needed
Available from: 31.Jeevanandam J, San Chan Y, Danquah MK
Publication bias and GRADE assessment As per the guidelines, a public bias assessment was not conducted for this study due to the limited number of included studies
Life Sci 361:123310 Iwamoto Y, Kimura T, Dan K, Iwamoto H, Sanada J, Fushimi Y et al (2024) Tirzepatide, a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, exhibits favourable effects on pancreatic -cells and hepatic steatosis in obese type 2 diabetic db/db mice